A study which determines if Dexamethasone reduces vomiting after laproscopic gall bladder removal surgery.
Not Applicable
Completed
- Conditions
- Health Condition 1: K802- Calculus of gallbladder without cholecystitis
- Registration Number
- CTRI/2019/08/020923
- Lead Sponsor
- ESI PGIMSR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
1. ASA Class 1-2
2. Patients undergoing elective laproscopic cholecystectomy
Exclusion Criteria
1. Patient refusal
2. Patients who are pregnant or who have uncontrolled diabetes, glaucoma (all patients had blood glucose concentrations checked to exclude undiagnosed hyperglycaemia).
3. Those with a known adverse reaction to dexamethasone or who were taking any systemic steroids (excluding steroid inhalers, suppositories, pessaries, eye drops, one-off local injections to a joint, or topical preparations) were excluded from the trial. 4. Patients previously taking regular oral or intravenous steroids had to have stopped taking these drugs at least three months before trial entry to be eligible.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method